Indefinite Delivery Contract SPE2D017D0002
Award Date
11/16/16
Last Date to Order
11/15/26
Federal Agency
Medical Supply Chain
Awardee
Astrazeneca Pharmaceuticals LP
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to AstraZeneca Pharmaceuticals LP, a foreign-owned, for-profit pharmaceutical manufacturer. The IDC, valued at $24,672,000.00, is for the procurement of adult influenza vaccines for the 2020-2021 timeframe.
As a multiple award IDC, this contract vehicle allows the CDC to issue task orders to AstraZeneca and other qualified vendors to fulfill adult influenza vaccine requirements....
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Centers for Disease Control and Prevention (CDC), a civilian federal agency, to AstraZeneca Pharmaceuticals LP, a foreign-owned, for-profit pharmaceutical manufacturer. The contract ceiling value is $15,136,570.80 with a period of performance through February 28, 2025. The purpose of this IDC is to procure pediatric influenza vaccines for the 2024-2025 timeframe. AstraZeneca, a leading global biopharmaceutical company, has a...
This Indefinite Delivery Contract (IDC) is a multiple-award vehicle awarded by the Centers for Disease Control and Prevention (CDC), a civilian federal agency under the Department of Health and Human Services, to AstraZeneca Pharmaceuticals LP, a foreign-owned, for-profit pharmaceutical manufacturer. The contract has a ceiling value of $8,820,000.00 and a period of performance through February 28, 2025, for the procurement of adult influenza vaccines during the 2024-2025 flu...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract with the Department of Veterans Affairs (VA) for pharmaceutical and medical products. The prime contractor is AstraZeneca Pharmaceuticals LP, a foreign-owned, for-profit pharmaceutical manufacturer. The contract has a ceiling value of $11,746,924,720 and runs from September 30, 2019 to September 30, 2025.
Under this IDV, AstraZeneca has been awarded multiple task orders to provide vaccines, therapeutics, and other...
This indefinite delivery contract was awarded by the Centers for Disease Control and Prevention (CDC) to Astrazeneca Pharmaceuticals LP, a foreign-owned, for-profit pharmaceutical manufacturer. The $47.2 million, multiple-award contract, with a period of performance through February 2021, is for the procurement of pediatric influenza vaccines.
Astrazeneca is a leading global biopharmaceutical company that has supplied various pharmaceutical products, medical treatments, and medical...
This indefinite delivery contract was awarded by the Centers for Disease Control and Prevention (CDC), a civilian agency within the Department of Health and Human Services (HHS), to AstraZeneca Pharmaceuticals LP, a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $377,600,000.00, is for the procurement of influenza vaccines to support adult and pediatric immunization programs.
AstraZeneca, a leading global biopharmaceutical company, has a history of providing...
This indefinite delivery contract was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to AstraZeneca Pharmaceuticals LP, a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $377,812,500, is for the supply of anti-interleukin monoclonal antibody products, specifically benralizumab, for use by the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract has a base period of one year from...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $999,999,999 and runs through November 2026. It serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contracted items include specialty...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $999,999,999 IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty...
This indefinite delivery contract (IDC) was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian federal agency, to Glaxosmithkline, LLC, a pharmaceutical company, to provide a portfolio of new antibacterial drugs for hospital and biothreat pathogens. The single-award IDC has a ceiling value of $255,851,502.87 and a period of performance through September 30, 2029.
The contract aims to procure a range of pharmaceutical products and services from...